Stock Scorecard

Stock Summary for Vertex Pharmaceuticals Inc (VRTX) - $391.36 as of 9/16/2025 9:25:53 PM EST

Total Score

12 out of 30

Safety Score

68 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for VRTX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VRTX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VRTX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VRTX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VRTX (68 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VRTX

Why This Biotech Company Could Be a Growth Stock Powerhouse 9/17/2025 9:10:00 AM
NJ Healthy Aging Summit to Promote Wellness, Prevention, and Safer Pain Management for Older Adults 9/16/2025 2:05:00 PM
1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals 9/15/2025 11:30:00 AM
Vertex Pharmaceuticals Incorporated ( VRTX ) Is a Trending Stock: Facts to Know Before Betting on It 9/12/2025 1:00:00 PM
3 Absurdly Cheap Stocks to Buy for the Long Haul 9/12/2025 11:30:00 AM
Claire's Place Foundation's 11th Annual Glow Ride for CF Lights Up Hermosa Beach, Sept. 20 9/11/2025 7:46:00 PM
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years - Vertex Pharmaceuticals ( NASDAQ:VRTX ) 9/11/2025 4:00:00 PM
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190% 9/11/2025 7:45:00 AM
Vertex Pharmaceuticals ( VRTX ) Stock Slides as Market Rises: Facts to Know Before You Trade 9/10/2025 9:50:00 PM
NJ Healthy Aging Summit to Spotlight Opioid Safety and Alternatives for Older Adults 9/4/2025 5:39:00 PM

Financial Details for VRTX

Company Overview
Ticker VRTX
Company Name Vertex Pharmaceuticals Inc
Country USA
Description Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 6/30/2025
Next Earnings Date 11/10/2025

Stock Price History
Last Day Price 391.36
Price 4 Years Ago 219.60
Last Day Price Updated 9/16/2025 9:25:53 PM EST
Last Day Volume 1,691,534
Average Daily Volume 2,134,030
52-Week High 519.88
52-Week Low 362.50
Last Price to 52 Week Low 7.96%

Valuation Measures
Trailing PE 28.09
Industry PE 21.46
Sector PE 40.64
5-Year Average PE 52.98
Free Cash Flow Ratio 20.18
Industry Free Cash Flow Ratio 13.30
Sector Free Cash Flow Ratio 29.51
Current Ratio Most Recent Quarter 2.52
Total Cash Per Share 19.39
Book Value Per Share Most Recent Quarter 67.02
Price to Book Ratio 5.89
Industry Price to Book Ratio 29.01
Sector Price to Book Ratio 32.14
Price to Sales Ratio Twelve Trailing Months 8.86
Industry Price to Sales Ratio Twelve Trailing Months 42.18
Sector Price to Sales Ratio Twelve Trailing Months 19.15
Analyst Buy Ratings 16
Analyst Strong Buy Ratings 2

Share Statistics
Total Shares Outstanding 256,391,000
Market Capitalization 100,341,181,760
Institutional Ownership 98.15%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY -40.90%
Annual Earnings Growth -114.80%
Reported EPS 12 Trailing Months 14.00
Reported EPS Past Year 8.58
Reported EPS Prior Year 0.29
Net Income Twelve Trailing Months 3,637,600,000
Net Income Past Year -535,600,000
Net Income Prior Year 3,619,600,000
Quarterly Revenue Growth YOY 12.10%
5-Year Revenue Growth 21.50%
Operating Margin Twelve Trailing Months 38.90%

Balance Sheet
Total Cash Most Recent Quarter 4,972,200,000
Total Cash Past Year 4,569,600,000
Total Cash Prior Year 10,369,100,000
Net Cash Position Most Recent Quarter 4,972,200,000
Net Cash Position Past Year 4,569,600,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 16,409,600,000
Total Stockholder Equity Prior Year 17,580,400,000
Total Stockholder Equity Most Recent Quarter 17,175,400,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 3,499,700,000
Free Cash Flow Per Share Twelve Trailing Months 13.65
Free Cash Flow Past Year -790,300,000
Free Cash Flow Prior Year 3,278,900,000

Options
Put/Call Ratio 0.11
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -7.01
MACD Signal -9.34
20-Day Bollinger Lower Band 367.43
20-Day Bollinger Middle Band 434.50
20-Day Bollinger Upper Band 501.57
Beta 0.44
RSI 39.78
50-Day SMA 453.95
150-Day SMA 402.69
200-Day SMA 366.35

System
Modified 9/16/2025 12:48:11 PM EST